Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: Evidence from a large international database
ADULT;
ARTICLE;
BONE METASTASIS;
BRAIN METASTASIS;
CANCER CHEMOTHERAPY;
CANCER CLASSIFICATION;
CANCER GROWTH;
CANCER PATIENT;
DATA BASE;
GERM CELL TUMOR;
HUMAN;
LIVER METASTASIS;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL RECORD REVIEW;
OVERALL SURVIVAL;
POPULATION;
PRIORITY JOURNAL;
PROGNOSIS;
PROGRESSION FREE SURVIVAL;
RETROSPECTIVE STUDY;
SALVAGE THERAPY;
Dose-intensive chemotherapy in refractory germ cell cancer - A phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation
Nichols CR, Tricot G, Williams SD, et al: Dose-intensive chemotherapy in refractory germ cell cancer: A phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation. J Clin Oncol 7:932-939, 1989 (Pubitemid 19172468)
High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: A phase I/II study
Siegert W, Beyer J, Strohscheer I, et al: High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: A phase I/II study - The German Testicular Cancer Cooperative Study Group. J Clin Oncol 12:1223-1231, 1994 (Pubitemid 24173937)
High-dose versus conventional-dose chemotherapy as first-salvage treatment in patients with non-seminomatous germ-cell tumors: A matched-pair analysis
DOI 10.1093/annonc/mdf112
Beyer J, Stenning S, Gerl A, et al: High-dose versus conventional-dose chemotherapy as first-salvage treatment in patients with non-seminomatous germ-cell tumors: A matched-pair analysis. Ann Oncol 13:599-605, 2002 (Pubitemid 34461144)
Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors
DOI 10.1200/JCO.2005.19.638
Kondagunta GV, Bacik J, Donadio A, at al: Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. J Clin Oncol 23:6549-6555, 2005 (Pubitemid 46190247)
High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors
DOI 10.1056/NEJMoa067749
Einhorn LH, Williams SD, Chamness A, et al: High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors. N Engl J Med 357:340-348, 2007 (Pubitemid 47124134)
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours
DOI 10.1093/annonc/mdi228
Pico JL, Rosti G, Kramar A, et al: A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours. Ann Oncol 16:1152-1159, 2005 (Pubitemid 41418319)
Prognostic factors in patients with metastatic germ cell tumors who fail cisplatin-based first-line chemotherapy
International Prognostic Factor Study Group
International Prognostic Factor Study Group, Lorch A, Beyer J, et al: Prognostic factors in patients with metastatic germ cell tumors who fail cisplatin-based first-line chemotherapy. J Clin Oncol 28:4906-4911, 2010
High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors
Lorch A, Neubauer A, Hackenthal M, et al: High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors. Ann Oncol 21:820-825, 2010